Incyte Reports Strong Q1 2025 Financial Results and Pipeline Progress
WILMINGTON, DE — Incyte (Nasdaq: INCY) delivered strong first-quarter financial results for 2025, propelled by revenue growth across its key products and continued advances in its clinical portfolio. Total revenues …
Incyte Reports Strong Q1 2025 Financial Results and Pipeline Progress Read More